our team members
Ausovi Leadership Team
Ausovi’s leadership combines deep expertise in technology-driven innovation, financial strategy, operational excellence, and scientific collaboration to advance novel analog compounds from concept to impactful therapeutics. Our team is united by a commitment to precision, agility, and long-term value creation in biotechnology.
David Austin
Chief Executive Officer
George Hutchinson
Chief Financial Officer
Stephen Lenn
Chief Council-
Analog Design & Modeling
-
Synthesis & Optimization
-
Preclinical Validation
-
IP & Portfolio Strategy
-
Analog Design & Modeling
-
Synthesis & Optimization
-
Preclinical Validation
-
IP & Portfolio Strategy
Extended team members
Scientific & Strategic Advisors
Ausovi draws on independent expertise from leading figures in pharmacology, medicinal chemistry, and translational research. Our advisors provide critical guidance on analog optimization, preclinical strategies, and regulatory pathways, strengthening our scientific foundation and strategic direction.
Adam Halberstadt Ph.D.
Chief Scientist
Jason Wallach, Ph.D.
Lead Chemist
Elisabeth Austin
Chief Operating Officer-
Analog Design & Modeling
-
Synthesis & Optimization
-
Preclinical Validation
-
IP & Portfolio Strategy
-
Analog Design & Modeling
-
Synthesis & Optimization
-
Preclinical Validation
-
IP & Portfolio Strategy